PrEP

Landmark Deals Drop New Injectable PrEP From $28,000 to $40—for Some

Lenacapavir, the new long-acting HIV prevention medication that hit the United States market with a price tag of over $28,000…

September 24, 2025

The Barriers to PrEP Uptake Among People Who Inject Drugs

Since 2012, medications designed to protect people from contracting HIV have been hard at work. Pre-exposure prophylaxis (PrEP), as they're…

November 17, 2022

FDA Approves First Long-Lasting HIV PrEP Medication—But There’s a Catch

The FDA has approved the first injectable medication to protect against HIV transmission. Apretude is injected every other month, setting…

December 23, 2021

Syringe Programs Key to Connecting Women With PrEP, Research Shows

What is the best way to protect more women who use drugs from HIV treatment? Researchers examined one aspect this…

February 25, 2021